Xeomin
Stories
-
Huons Biopharma registers Phase 3 trial of HU-045 in glabellar lines
The study was first posted on ClinicalTrials.gov on October 13, 2026. It plans to enroll 390 participants and compares HU-045 to Xeomin in adults with moderate or severe glabellar lines.